Perspective Therapeutics, Inc.
XASE:CATX
2.33
$2.55 - 100.00
$2.32 - 1,000.00
$2.32
$2.47
$2.47
$2.48
5.39
1.6
1403315
1539823
61617801.81
Chart
TendieTensor AI Analysis
Company
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Fundamentals
140
-1.700000
0.761131
100
BBG000BG5HT7
BBG001S5Q300
74.26M
74.26M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CATX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.